The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-18 of 18 articles
Clopidogrel: still king of the ring for elective percutaneous coronary intervention!
March 20, 2023 | 10.4244/EIJ-E-23-00003
Economic evaluation of fractional flow reserve-guided versus angiography-guided multivessel revascularisation in ST-segment elevation myocardial infarction patients in the FLOWER-MI randomised trial
Le Bras A,
Puymirat E,
Rabetrano H,
Cayla G,
Simon T,
Steg G,
Montalescot G,
Varenne O,
Bonello L,
Coste P,
Delarche N,
Georges J,
Chassaing S,
Letocart V,
Chatellier G,
Danchin N,
Durand-Zaleski I
June 24, 2022 | 10.4244/EIJ-D-21-00867
Culprit lesion location and outcomes in patients with multivessel disease and infarct-related cardiogenic shock: a core laboratory analysis of the CULPRIT-SHOCK trial
Hauguel-Moreau M,
Barthélémy O,
Farhan S,
Huber K,
Rouanet S,
Zeitouni M,
Guedeney P,
Hage G,
Vicaut E,
Zeymer U,
Desch S,
Thiele H,
Montalescot G
August 6, 2021 | 10.4244/EIJ-D-20-00561
Beyond ischaemia: is there a place for physiologic and anatomic evaluations of coronary lesions?
July 20, 2021 | 10.4244/EIJV17I4A46
Angiographic predictors of outcome in myocardial infarction patients presenting with cardiogenic shock: a CULPRIT-SHOCK angiographic substudy
Overtchouk P,
Barthélémy O,
Hauguel-Moreau M,
Guedeney P,
Rouanet S,
Zeitouni M,
Silvain J,
Collet J,
Vicaut E,
Zeymer U,
Desch S,
Thiele H,
Montalescot G
February 5, 2021 | 10.4244/EIJ-D-20-00139
GLOBAL LEADERS: looking now at the bigger picture
December 20, 2019 | 10.4244/EIJV15I12A192
Impact of age on the effect of pre-hospital P2Y12 receptor inhibition in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: the ATLANTIC-Elderly analysis
Collet J,
Kerneis M,
Lattuca B,
Yan Y,
Cayla G,
Silvain J,
Lapostolle F,
Ecollan P,
Diallo A,
Vicaut E,
Hamm C,
van't Hof A,
Montalescot G
September 20, 2018 | 10.4244/EIJ-D-18-00182
The efficacy of early versus delayed P2Y12 inhibition in percutaneous coronary intervention for ST-elevation myocardial infarction: a systematic review and meta-analysis
Bellemain-Appaix A,
Begue C,
Bhatt D,
Ducci K,
Harrington R,
Roe M,
Wiviott SD,
Cucherat M,
Silvain J,
Collet J,
Bernasconi F,
Montalescot G
May 20, 2018 | 10.4244/EIJ-D-17-00852
Outcome after revascularisation of acute myocardial infarction with cardiogenic shock on extracorporeal life support
Overtchouk P,
Pascal J,
Lebreton G,
Hulot J-S,
Luyt C-E,
Combes A,
Kerneis M,
Silvain J,
Barthelemy O,
Leprince P,
Brechot N,
Montalescot G,
Collet J
April 6, 2018 | 10.4244/EIJ-D-17-01014
Intravenous enoxaparin anticoagulation in percutaneous left atrial cardiac procedures
Guedeney P,
Hammoudi N,
Duthoit G,
Yan Y,
Silvain J,
Pousset F,
Isnard R,
Redheuil A,
Kerneis M,
Collet J,
Montalescot G
November 20, 2017 | 10.4244/EIJ-D-17-00518
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry
Lu H,
Grundeken M.J,
Vos N,
IJsselmuiden A,
van Geuns R,
Wessely R,
Dengler T,
La Manna A,
Silvain J,
Montalescot G,
Spaargaren R,
Thijssen J,
Amoroso G,
de Winter RJ,
Koch K
August 4, 2017 | 10.4244/EIJ-D-16-00676
Will PIONEER AF-PCI change my practice?
August 4, 2017 | 10.4244/EIJV13I5A95
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
Fabris E,
van't Hof A,
Hamm C,
Lapostolle F,
Lassen J,
Goodman S,
ten Berg J,
Bolognese L,
Cequier A,
Chettibi M,
Hammett C,
Huber K,
Janzon M,
Merkely B,
Storey R,
Zeymer U,
Cantor W,
Rousseau H,
Vicaut E,
Montalescot G
May 15, 2017 | 10.4244/EIJ-D-16-00965
STENTYS Self-Apposing® sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial
van Geuns R,
Yetgin T,
La Manna A,
Tamburino C,
Souteyrand G,
Motreff P,
Koch K,
Vrolix M,
IJsselmuiden A,
Amoroso G,
Berland J,
Montalescot G,
Teiger E,
Christiansen E,
Spaargaren R,
Wijns W
February 12, 2016 | 10.4244/EIJV11I11A248
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study
Povsic T,
Vavalle J,
Alexander J,
Aberle L,
Zelenkofske S,
Becker R,
Buller C,
Cohen M,
Cornel J,
Kasprzak J,
Montalescot G,
Fail P,
Sarembock I,
Mehran R
August 19, 2014 | 10.4244/EIJY14M06_01
Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field?
September 15, 2013 | 10.4244/EIJV9SSA9
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study
Bayard Y-L,
Omran H,
Neuzil P,
Thuesen L,
Pichler M,
Rowland E,
Ramondo A,
Ruzyllo W,
Budts W,
Montalescot G,
Brugada P,
Serruys P,
Vahanian A,
Piéchaud JF,
Bartorelli AL,
Marco J,
Probst P,
Kuck K,
Ostermayer S,
Büscheck F,
Fischer E,
Leetz M,
Sievert H
June 30, 2010
Latest news
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
AHEAD OF PRINT
Navitor CE mark cohort outcomes
FREE ARTICLE - Lars Sondergaard et al
March 9, 2023
AHEAD OF PRINT
One-year SAPIEN 3U registry results
FREE ARTICLE - Stefano Cannata et al
March 7, 2023
AHEAD OF PRINT
The POT-PUFF sign: an angiographic mark of stent malapposition during proximal optimisation
FREE ARTICLE - Farhang Aminfar et al
March 3, 2023